FDA Unveils Draft Guidance to Boost Diversity in Clinical Trials
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) is taking significant steps to ensure that clinical trials better reflect the diversity of the population they aim to serve. …
FDA Unveils Draft Guidance to Boost Diversity in Clinical Trials Read More